Skip to content
  • Tuesday, May 13, 2025
FrankTrades.com | Stock Market News, Stock Options Flow, Dark Pool, Product Reviews & more!

FrankTrades.com | Stock Market News, Stock Options Flow, Dark Pool, Product Reviews & more!

Frank is Frank

TradingView - Try it now!

  • Loading stock data...

  • Home
  • News
  • Blog
    • Rants
    • Stock Market Weekly Briefing
    • Motivate
    • Thoughts
  • Reviews
    • Books
    • Films
    • Recommendations
  • Film
  • Investing Tools
    • BlackBoxStocks
    • Tradingview
    • M1 Finance
    • Tastyworks
  • Referrals
  • Resources
    • Quizzes
    • Articles
    • Class Action Lawsuits
  • Subscribe
  • Home
  • 2023
  • March
  • 20
  • 📰 Thermo Fisher, Celltrion Vie for Baxter’s Biopharma Unit: Rtrs $BAX $TMO
News

📰 Thermo Fisher, Celltrion Vie for Baxter’s Biopharma Unit: Rtrs $BAX $TMO

March 20, 2023
Frank

Thermo Fisher, Celltrion Vie for Baxter’s Biopharma Unit: Rtrs $BAX $TMO

Share this:

  • Click to share on X (Opens in new window) X
  • Click to share on X (Opens in new window) X
  • Click to share on Facebook (Opens in new window) Facebook
  • Click to share on Reddit (Opens in new window) Reddit
  • Click to share on LinkedIn (Opens in new window) LinkedIn

Like this:

Like Loading...
Tags: Stock Market, Tweet

Post navigation

📰 Amazon job cuts rise to 27,000, but it’s still not enough to rightsize the company – CNBC $AMZN
📰 (Bloomberg) –The Federal Reserve shouldn’t raise its benchmark rate this week, Pershing Square’s Bill Ackman said, arguing that the banking crisis has already had the effect of a “meaningful tightening of financial conditions

Reviews

Film Reviews Letterboxd Reviews

Watched: Thelma, 2024 – ★★★★★

June 30, 2024
Frank
Books Goodreads Reviews

‘Joyful Recollections of Trauma’ by Paul Scheer

June 8, 2024
Frank
Film Reviews Films Reviews

Dumb Money (2023)

January 24, 2024
Frank
Reviews

One Second After by William R. Forstchen

April 15, 2023
Frank

August 12, 2020
1736 days ago.

    Trading involves substantial risk of loss and is not suitable for every investor.
    The information provided should not be considered as a recommendation or financial advice. Information provided in this poorly written blog shouldn’t be considered as a recommendation or financial advice, but only opinion. Few links may be affiliated.

    Visits

    • 13,376
    Privacy Policy
    %d